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ACKGROUND: Recent evidence suggested 
that we grow old partly because of our stem cells 
grow old as a result of mechanisms that suppress 
the development of cancer over a lifetime. We believe 
that a further, more precise mechanistic understanding of 
this process will be required before this knowledge can be 
translated into human anti-aging therapies.
CONTENT: A diminished capacity to maintain tissue 
homeostasis is a central physiological characteristic of 
aging. As stem cells regulate tissue homeostasis, depletion 
of stem cell reserves and/or diminished stem cell function 
have been postulated to contribute to aging. It has further 
been suggested that accumulated DNA damage could be 
a principal mechanism underlying age-dependent stem 
cell decline. It is interesting that many of the rejuvenating 
interventions act on the stem cell compartments, perhaps 
relecting shared genetic and biochemical pathways 
controlling stem cell function and longevity. Strategy 
to slow down the aging processes is based on caloric 
restriction refers to a dietary regimen low in calories but 
Abstract
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without undernutrition. Sirtuin (SIRT)1 and 3, increases 
longevity by mimicking the beneicial effects of caloric 
restriction. SIRT3 regulates stress-responsive mitochondrial 
homeostasis, and more importantly, SIRT3 upregulation 
rejuvenates aged stem cells in tissues. Resveratrol 
(3,5,4’-trihydroxystilbene), a natural polyphenol found in 
grapes and wine, was the most powerful natural activator of 
SIRT1. In fact, resveratrol treatment has been demonstrated 
to rescue adult stem cell decline, slow down bodyweight 
loss, improve trabecular bone structure and mineral density, 
and signiicantly extend lifespan.
SUMMARY: Tissue-speciic stem cells persist throughout 
the entire lifespan to repair and maintain tissues, but 
their self-renewal and differentiation potential become 
dysregulated with aging. Given that adult stem cells are 
thought to be central to tissue maintenance and organismal 
survival, SIRT3 may promote organismal longevity by 
maintaining the integrity of tissue-speciic stem cells.
KEYWORDS:  rejuvenation, aging, stem cell, DNA 
damage, sirtuin activator
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Introduction
Aging is characterized by a progressive loss of physiological 
integrity, leading to impaired function and increased 
vulnerability to death. This deterioration is the primary 
risk factor for major human pathologies, including cancer, 
diabetes, cardiovascular disorders, and neurodegenerative 
diseases.(1) Aging, which we broadly deine as the time-
dependent functional decline that affects most living 
organisms, has attracted curiosity and excited imagination 
throughout the history of humankind. For thousands of 
years humanity has searched for the fountain of youth. In 
the 16th century the Spanish explorer Juan Ponce de León, 
irst Governor of Puerto Rico, searched for the fountain of 
youth in the legendary land of Florida, speciically in the 
waters of Bimini, but without success. This quest continues, 
although all living species on our planet are designed to age.
(2)
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 The underlying cause of aging remains one of the 
central mysteries of biology. Recent studies in several 
different systems suggest that not only may the rate of aging 
be modiied by environmental and genetic factors, but also 
that the aging clock can be reversed, restoring characteristics 
of youthfulness to aged cells and tissues.(3) Aging is 
associated with a gradual loss of homeostatic mechanisms 
that maintain the structure and function of adult tissues. A 
major challenge of aging research has been to distinguish the 
causes of cell and tissue aging from the myriad of changes 
that accompany it. One of the hallmarks of cellular aging is 
an accumulation of damaged macromolecules such as DNA, 
proteins, and lipids. These become chemically modiied by 
reactive molecules, such as free radicals, that are generated 
during normal cellular metabolism and whose production 
increases with age.(4)
 At the cellular level, aging induces many potentially 
interconnected defects, including DNA damage in the 
nucleus and mitochondria, mitochondrial dysfunction 
leading to increased production of reactive oxidative species 
(ROS) and decreased production of ATP, oxidative damage 
to proteins and other macromolecules in cells, protein 
misfolding and aggregation, protein glycation, the induction 
of proinlammatory cytokines, telomere shortening, and cell 
senescense.(1) These will impact mitotically active tissues 
over time by triggering stem cell depletion by senescence 
and apoptosis (e.g., intestinal stem cell, hematopoietic 
stem cell (HSC), mesenchymal stem cell (MSC), etc.), and 
postmitotic tissues by causing cellular dysfunction and loss 
(e.g., muscle, heart, and brain). Beyond tissue-autonomous 
aging, it is now clear that the brain helps govern aging of 
many organs (5,6), i.e., dysfunction in the hypothalamus 
will exert systemic effects leading to functional decline and 
damage to cells and organs.(7)
 Stem cells, through their regenerative ability, 
maintain tissue homeostasis during an individual’s lifespan. 
However, stem cell-associated mechanisms of tissue repair 
become impaired with aging. Very interestingly, a recent 
study demonstrated that Sirtuin (SIRT)3, which is highly 
expressed in HSC, is not essential for tissue repair at a 
young age under physiological conditions; however, it is 
crucial at an old age. Moreover, it is important to highlight 
that induced SIRT3 overexpression, which is suppressed 
with aging, signiicantly improves aged HSC’s regenerative 
power.(8) The recent implication of a role for SIRT in the 
ield of regenerative medicine also suggests their possible 
application in stem cell therapy. The scientiic community 
has not yet found the fountain of youth; however, the SIRT 
story thus far seems the closest to Ponce de León’s water of 
Bimini.(2)
The aging process is an inevitable consequence of life. As 
a result of exposure to intrinsic, as well as extrinsic aging 
factors, cellular aging is triggered by gradually accumulating 
DNA damage and epigenetic changes in DNA’s structure.(9-
11) Thus, aging could be envisioned at the cellular level as 
a result of altered cell function in response to changes in the 
DNA structure that directly affect proper gene expression.
(12) With age, there is a gradual decline in the regenerative 
properties of most tissues due to a combination of age-
dependent changes in tissue-speciic stem cells and in the 
environmental cues that promote those cells to participate 
in tissue maintenance and repair.(13) These rare and 
specialized adult stem cell (ASC) are required for tissue 
replacement throughout the human lifespan, and appear 
to be characterized by a few speciic physiological and 
biochemical properties, particularly the capacity for self-
renewal.(14-17)
 Mechanisms that suppress the development of cancer, 
such as senescence and apoptosis, which rely on telomere 
shortening and the activities of p53 and p16INK4a may also 
induce an unwanted consequence: a decline in the replicative 
function of certain stem cells types with advancing age. 
This decrease regenerative capacity appears to pointing 
to the “stem cell hypothesis of aging”.(17) Many of the 
pathophysiological conditions aflicting the elderly, such as 
anemia, sarcopenia, and osteoporosis, suggest an imbalance 
between cell loss and renewal. The fact that homeostatic 
maintenance and regenerative potential of tissues wane 
with age has implicated stem cell decline as a central player 
in the aging process. However, the degree to which aging 
is attributable to stem cell dysfunction or instead relects 
a more systemic degeneration of tissues and organs will 
likely differ substantially between different tissues and their 
resident stem cells.(18)
 Many of the pathophysiological conditions aflicting 
the elderly, such as anemia, sarcopenia, and osteoporosis, 
suggest an imbalance between cell loss and renewal. The 
fact that homeostatic maintenance and regenerative potential 
of tissues wane with age has implicated stem cell decline as 
a central player in the aging process. However, the degree 
to which aging is attributable to stem cell dysfunction or 
instead relects a more systemic degeneration of tissues 
and organs will likely differ substantially between different 
tissues and their resident stem cells.(18)
 ASC populations maintain highly differentiated but 
short-lived cells such as blood, intestinal epithelium cells, 
and sperm throughout life. Upon division of stem cells, 
Stem Cell Hypothesis of Aging
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daughter cells must either self-renew to preserve stem 
cell identity or commit to differentiation. The balance 
between stem cell self-renewal and differentiation is critical 
to tissue homeostasis, with disruption of this balance 
leading to tumorigenesis (caused in some cases by stem 
cell overproliferation) or tissue degeneration (caused by 
stem cell depletion). A decline in the function of ASC and 
their supportive niches has been proposed to contribute to 
tissue aging, although the underlying mechanisms remain 
enigmatic.(19,20) Tissue aging has been proposed to have 
arisen as a tumor suppressor mechanism (21-24), in which 
tumor suppressor activity reduces stem cell function in later 
stages of life, preventing tumorigenesis but reducing tissue 
regenerative capacity.
 Most studies of the effects of aging on ASC focus 
upon the HSC and the age-related changes they undergo 
are well documented. We have attempted to summarize 
the age-related changes affecting HSCs. HSC numbers 
do not decrease with age rather, the proportion of Cluster 
of Differentiation (CD)34+/CD38 or Lin/CD34+/CD38/
CD90+/CD45RA increases in the elderly bone marrow 
of humans and mice, respectively,(25,26) but these cells 
show a number of functional differences to their youthful 
counterparts. The increasing preference for myeloid over 
lymphoid differentiation has already been noted (27), 
but why this should occur is not completely understood. 
One suggestion is that the relative percentage of myeloid 
committed progenitors increases with age at the expense of 
lymphoid committed cells although we do not know if such 
bias is due to an intrinsic change in the properties of HSC 
or if it simply arises because HSC that were committed to 
a myeloid fate earlier in the life of the individual become 
more numerous.
 Epigenetic changes in HSCs as a function of age have 
been recorded by other workers. To identify transcriptional 
changes in aged HSCs that correlate with their known 
functional deicit. Most of the genes that were consistently 
upregulated in aged HSCs belonged to categories 
previously linked to aging in general such as nitric oxide-
mediated signal transduction systems, protein folding, 
and inlammatory responses; however, genes undergoing 
substantial downregulation with age tended to be those 
involved in the preservation of genomic integrity such as 
chromatin remodeling and DNA repair.(18,28)
 Stem cells must change their properties throughout life 
to match the changing growth and regeneration demands of 
tissues. Stem cells divide rapidly during fetal development 
to support rapid growth. By young adulthood, growth has 
slowed or ceased in mammalian tissues and most stem 
cells are quiescent most of the time, intermittently dividing 
to maintain tissue homeostasis. In old adults, stem cells 
increase gate-keeping tumor suppressor expression. This 
may reduce the incidence of cancer in aging tissues, but 
also reduces regenerative capacity.(29-31) These changes in 
stem cells likely relect regulation by heterochronic genes, 
genes whose expression changes over time in a way that 
causes temporal changes in stem cell function.(32-33)
 ASCs are known to be mostly quiescent and to rarely 
enter cell cycle.(34) The few exceptions, such as intestinal 
stem cells (35), are the subject of debate.(36,37) It has been 
postulated that quiescence protects stem cells from incurring 
damage during cell division and plays a necessary role in 
their lifetime maintenance. Nonetheless, when faced with 
major tissue loss or damage, stem cells exit their quiescent 
state and enter the cell cycle to proliferate and generate large 
numbers of differentiated progenies. These properties may 
be shared by cancer stem cells.(38)
 Recently, the progeroid phenotype of the mitochondrial 
DNA (mtDNA) mutator mice has been, at least partly, 
attributed to embryonic-onset dysfunction of somatic 
stem cells.(39) Ahlqvist and coworkers demonstrated that 
development of neural and hematopoietic progenitor cells 
of the mtDNA mutator mice is already affected during fetal 
development, and that neural stem cells showed decreased 
abundance in vivo as well as reduced self-renewal in vitro.
(40) Their data suggest that mtDNA mutagenesis affects the 
quality and quantity of stem cells and interferes with the 
maintenance of the quiescent state, which is important for 
reconstitution capacity and long-term sustenance of somatic 
stem cells.(41)
 The observation that treatment with the antioxidant 
N-acetyl cysteine restores the self-renewal ability of neural 
progenitor cells in mtDNA mutator mice (65) implies that 
subtle changes in cellular redox state or ROS levels are 
important for the regulation of somatic stem cell function 
(Figure 1). Mitochondrial activity, tissue growth, and 
metabolic rates during development can also inluence life 
span and the rates of cellular aging at later stages of life.
(42) Thus, the aging of stem cells cannot be considered in 
isolation but rather in the context of temporal changes in 
stem cell and tissue properties that occur throughout life. 
Like all cells, stem cell aging is determined partly by the 
accumulation of damage over time. Declines in stem cell 
function during aging can be precipitated by telomere 
shortening, DNA damage, and mitochondrial damage.(43-
45) Stem cell aging can be slowed by dietary restriction 
(46-49) and by exposure to humoral factors from a young 
parabiont (sharing circulation with an old mouse) (50,51).
60
The Indonesian Biomedical Journal, Vol.7, No.2, August 2015, p.57-72 Print ISSN: 2085-3297, Online ISSN: 2355-9179
Figure 1. Model for mtDNA mutations in the stem cell 
hypothesis of aging.(41) (Adapted with permission from 
American Society for Clinical Investigation).
Stem Cell Niche Maintenance During 
Homeostasis and Regeneration
Most mammalian adult tissues contain resident stem cells, 
which proliferate to compensate for tissue loss throughout 
the life of the organism. They possess remarkable 
proliferative capacity, allowing them to engage in massive 
and repetitive regenerative activities in response to tissue 
damage. A subset of tissue-speciic ASC persists in the 
quiescent state for prolonged periods of time.(52) Whereas 
quiescence is not an essential characteristic that deines stem 
cells, dysregulation and loss of quiescence often results in an 
imbalance in progenitor cell populations ultimately leading 
to stem cell depletion.(53) As a result, tissue replenishment 
is affected during homeostasis and following damage. Thus, 
deciphering the regulation of quiescence will contribute 
much to our understanding of how tissue regeneration is 
accomplished in physiological and pathological settings 
and may lead to new therapeutic strategies for tissue 
maintenance or repair.(54)
 As demonstrated by studies of different stem cell 
compartments, one of the consequences of inhibiting 
essential signaling pathways that maintain the quiescent 
state is the premature activation or differentiation of stem 
cells. This is often followed by the exhaustion of the stem 
cell pool and results in impaired tissue homeostasis and 
regeneration, highlighting the importance of maintaining 
stem cell quiescence for tissue and organismal health. In 
some tissues, quiescent stem cells seem to serve as a reserve 
pool of stem cells and are only called into action upon tissue 
injury.
 Recent advances in ASC isolation have provided 
insights into the epigenetic, transcriptional and post-
transcriptional control of quiescence and suggest that 
quiescence is an actively maintained state in which 
signaling pathways are involved in maintaining a poised 
state that allows rapid activation. Deciphering the molecular 
mechanisms regulating ASC quiescence will increase 
our understanding of tissue regeneration mechanisms 
and how they are dysregulated in pathological conditions 
and in aging. In addition to the intrinsic mechanisms that 
regulate stem cell quiescence, the stem cell niche (that is, 
a speciic microenvironment that surrounds stem cells and 
has important regulatory functions) is essential for stem 
cell maintenance, including the maintenance of quiescence.
(54,55)
 A deining feature of stem cells is their ability to 
continuously maintain a balanced number of stem cells 
(self-renewal) while being able to generate specialized 
progeny (differentiation). An additional feature of stem 
cells is their ability to migrate. Therefore, stem cells are 
unique as they are able to balance four possible fates within 
a single cell: quiescence, migration, proliferation, and 
differentiation. These fate decisions are made in the context 
of the supporting stroma cells they adhere to, also referred 
to as the niche.(56) ASCs are found in speciic locations or 
niches that are ultimately responsible for the maintenance 
of stem cell populations, their controlled proliferation and 
the differentiation of their progeny into multiple cellular 
lineages. Niches provide stem cells speciic signals and 
physical support in the form of specialized cells and/or 
extracellular matrix (ECM).(57-61)
 The bone marrow niche has mystiied scientists for 
many years, leading to widespread investigation to shed light 
into its molecular and cellular composition. Considerable 
efforts have been devoted toward uncovering the regulatory 
mechanisms of HSC niche maintenance. Hematopoiesis is 
a continuous process of blood-cell production occurring 
through the orchestrated proliferation, self renewal and 
differentiation of HSCs in the bone marrow followed by 
egress of mature progeny into the circulating blood.(62-65) 
HSCs are the only cells capable of producing all blood cell 
lineages throughout life.(66) Within the bone marrow exists 
a tightly controlled local microenvironment, or niche, that 
regulates the quiescence, proliferation and differentiation of 
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HSCs.(67) Regulatory signals within the niche emanate from 
surrounding cells in the form of bound or secreted molecules 
and also from physical cues such as oxygen tension, shear 
stress, contractile forces and temperature.(65,68,69) During 
homeostasis, the majority of HSCs are quiescent but can 
become activated to proliferate and differentiate in response 
to infectious stress such as interferon- mediated signaling.
(71-73)
 MSC are adult tissue committed stem cells found 
in the bone marrow and other tissues that are capable of 
mobilizing, proliferating, and committing to terminally 
differentiated cell types such osteoblasts, adipocytes, 
chondrocytes, tenocytes, and myocytes.(75,76) It has also 
been noted that MSC may be capable of differentiating 
Figure 2. The HSC Niche.(61) (Adapted with 
permission from Nature Publishing Group).
Figure 3. The vascular niche’s effect on regeneration.(74) (Adapted with permission from Nature Publishing Group).
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into other lineages  such as  neurons,  glial cells,  and 
hepatocytes.(77-79) The ability to generate these two cells 
types coupled to their anatomical location in the bone 
marrow indicates that MSC may be a key component of the 
niche that supports and controls the activity of HSCs.
 Published evidence suggests that MSC functionality 
changes with donor age; primarily this involves alterations 
in their differentiation capacity namely reduced myogenic 
and osteogenic differentiation coupled to enhanced 
adipogenesis. These alterations in differentiation ability 
seem to depend on anatomical location; for example, the 
effectiveness of the hematopoietic niche may be diminished 
by reducing MSC differentiation to osteoblasts in favor of 
adipocytes.(18)
 Stem cell aging underlies the aging of tissues, 
especially those with a high cellular turnover. There is 
growing evidence that the aging of the immune system 
is initiated at the very top of the hematopoietic hierarchy 
and that the aging of HSC directly contributes to changes 
in the immune system, referred to as immunosenescence.
(60) Aging is known to affect directly stem cells (intrinsic 
factors) and to provoke changes in their microenvironment 
(extrinsic factors). In either case, the modiications in the 
stem cells and their niches result in impaired niche activity.
 Aging negatively affects several aspects of HSC 
function through both intrinsic and microenvironment-
mediated mechanisms, leading to decreased self renewal, 
loss of cell polarity, impaired homing ability and a biased 
differentiation into the myeloid lineage. Intrinsic effects 
include increased ROS levels leading to DNA damage and 
replicative senescence. Additional consequences of intrinsic 
changes include stem cell exhaustion and decreased 
hematopoietic cell repopulation capacity, as well as 
reduced survival rates. Observed extrinsic changes include 
decreased adhesion to bone marrow stromal cells and 
increased adipocyte numbers with aging, leading to reduced 
hematopoietic activity.(74) The ability of organs to adapt 
to cellular dysfunction, physical damage or physiological 
changes relies heavily on the properties of stem cells and 
niches. Both homed stem cell populations and their support 
microenvironments provide tissues with the plasticity 
necessary for their adaptation to local or systemic variations, 
a characteristic that allows organs respond to nutritional 
stress or aging, among other challenges.
Aging is the largest risk factor for most chronic diseases, 
which account for the majority of morbidity and health care 
expenditures in developed nations. New indings suggest 
that aging is a modiiable risk factor, and it may be feasible 
to delay age-related diseases as a group by modulating 
Figure 4. The effects of aging on HSC behavior.(74) (Adapted with permission from Nature Publishing Group).
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fundamental aging mechanisms. One such mechanism is 
cellular senescence, which can cause chronic inlammation 
through the senescence-associated secretory phenotype 
(SASP).(80) Cellular senescence refers to the essentially 
irreversible growth arrest that occurs when cells experience 
potentially oncogenic insults.(81-86) There is now strong 
evidence that cellular senescence is a potent anticancer 
mechanism.(87-90)
 Senescence-causing inducers include repeated cell 
division and strong mitogenic signals, telomere shortening, 
DNA damage and mutations, protein aggregation, and 
increased ROS.(91-96) These insults activate the p53 and 
p16INK4a tumor suppressor pathways and potentially other 
pathways that initiate a senescence response. Once initiated, 
senescence takes days to weeks to become fully established 
and irreversible. The process is reinforced by an intracellular 
signaling loop including ROS linked to DNA damage 
response (DDR), nuclear factor kappa-light-chain-enhancer 
of activated B cells (NF-κB), and transforming growth 
factor-β (TGFβ), as well as an Interleukin (IL)-1α, IL-6, 
and Cytidine-Cytidine-Adenosine-Adenosine-Thymidine 
(CCAAT) enhancer binding protein-β (C/EBP-β) loop.
(95,97-100) Senescent cells reorganize chromatin, resulting 
in heterochromatin formation, extensive gene expression 
changes, increased cell size and protein content, and changes 
in cell and organelle shape.(101-103) Senescent cells are 
metabolically active, relatively resistant to apoptosis, and 
appear to be removed by the immune system.(104-106) 
Senescence is effectively a cell fate that, like replication, 
differentiation, or apoptosis, can occur at any point in life.
 Chronic inlammation may also derive in part from 
senescent cells: senescent cells secrete proinlammatory 
cytokines, chemokines, and proteases, termed the SASP.
(106,107) The SASP is primarily a DDR.(108) The 
SASP, through the inlammatory, growth-promoting, and 
remodeling factors that it produces, can potentially explain 
how senescent cells alter tissue microenvironments, attract 
immune cells, and, ironically, induce malignant phenotypes 
in nearby cells. Proteins that are associated with the SASP, 
such as tumor necrosis factor (TNF)-α, IL-6, matrix 
metalloproteinases (MMP), monocyte chemoattractant 
protein-1 (MCP-1), and insulin-like growth factor-
binding protein (IGFBP), increase in multiple tissues with 
chronological aging (100), and occur in conjunction with 
sterile inlammation. Furthermore, expression of the SASP 
components, IL-6, IGFBP-2, and plasminogen activator 
inhibitor-1, is much higher in p16INK4a-positive senescent 
cells isolated directly from fat tissue of older progeroid mice 
compared with non-senescent cells from the same tissue.
(109) This inding suggests that the SASP is the main driver 
of age-related inlammation, at least in fat tissue under 
certain conditions. Thus, selective elimination of senescent 
cells or their effects might be a means to reduce age-related 
sterile chronic inlammation, enhance health span, and 
interrupt the link between aging and chronic disease.(80)
 Senescence is to initiate a sequence of processes that 
eliminate damaged cells and culminate in tissue regeneration 
(we refer to this sequence of events as senescence-clearance-
regeneration). However, this beneicial process can be 
corrupted, particularly in aged tissues, by a combination 
of factors: on the one hand, clearance of senescent cells by 
the immune system may become impaired leading to a net 
accumulation of senescent cells, which may further aggravate 
tissue dysfunction through the SASP (100,110); on the other 
hand, senescence may not only affect differentiated cells but 
also stem and progenitor cells, thus limiting the regenerative 
capacity of tissues. The combination of ineficient clearance, 
excessive SASP and ineffective regeneration may explain 
the accumulation of senescence during aging and its active 
contribution to some aging phenotypes.(111)
 In order to offset the detrimental effects of aging, 
stem cells have evolved reinforcing mechanisms to ensure 
the maintenance of their genomic integrity.(112) When 
those error-prevention checkpoints fail, tumor suppressor 
mechanisms such as senescence and apoptosis are activated.
(113) Over time, cellular senescence characterized by 
cell cycle arrest limits the ability of stem cells to replace 
damaged or dysfunctional cells.(97,114) Therefore, although 
senescence reduces oncogenic risk, this is at the expense 
of limiting the replicative capacity of stem cells, delaying 
tissue repair and ultimately promoting aging.(97,114-116)
 Therefore, the elimination of senescent cells is a 
promising strategy to reduce chronic systemic inlammation 
and to rejuvenate tissues.(117,118) In summary, senescence 
is a response that is primarily designed to eliminate 
damaged cells; however, with advancing age, the full 
sequence of senescence-clearance-regeneration is not 
entirely accomplished and senescence may become part 
of the problem rather than its solution. As a result of 
this duality, senescence is considered an example of 
‘antagonistic pleiotropy’ (1) and it has been categorized as 
an ‘antagonistic’ hallmark of aging (119).
The phenomenon of aging is an intrinsic feature of life. 
Accordingly, the possibility to manipulate it has fascinated 
humans likely since time immemorial. Recent evidence is 
shaping a picture where low caloric regimes and exercise may 
improve healthy senescence, and several pharmacological 
Caloric Restriction (CR), SIRT and Aging
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strategies have been suggested to counteract aging.(120) 
There are only a few proposed aging interventions that have 
met such stringent criteria: fasting regimens, CR, exercise, 
and the use of low-molecular-weight compounds, including 
spermidine, metformin, resveratrol, and rapamycin. From a 
molecular point of view, these interventions may act through 
epigenetic mechanisms (histone acetylation/methylation), 
the insulin/target of rapamycin (TOR) pathway, the Rat 
Sarcoma (Ras) signaling pathway, mitochondrial function, 
proteostasis, autophagy, and stress resistance.(120)
 The reduction in the intake of calories without 
malnutrition is deined as CR. Such reduction ideally 
corresponds to a decrease of approximately 30% of calories 
per day, at least in mice. In humans, there is some indication 
that a CR of around 15% may be most favorable against 
mortality during aging.(121) CR reduces the release of 
growth factors like growth hormone, insulin, and insulin-
like growth factor (IGF)-1, which have been shown to 
accelerate aging and increase mortality in many organisms.
(122) CR-mediated longevity in eukaryotes seems to be 
governed by a set of conserved nutrient signaling pathways.
(122) Among them are the insulin and the TOR/S6K 
pathways, whose inhibition upon CR eventually confers 
stress resistance and promotes survival during aging. Stress-
related transcription factors represent the common effectors 
in yeast, lies, worms, and mammals.(122) Moreover, the 
histone deacetylase single information regulator (Sir)2 (the 
founding member of the SIRT family) has been linked to 
CR-mediated antiaging effects in yeast mother cells, lies, 
and mammals.(123) SIRT-mediated control of protein 
acetylation might not be restricted to chromatin packaging 
and transcriptional modulation, as the mitochondrial SIRT, 
SIRT3 has been proposed to play an important role in 
the prevention of age-related diseases, possibly through 
modulation of the mitochondrial acetylproteome.(124)
 The original proposal was based on the indings that 
SIRT were nicotinamide adenine dinucleotide (NAD+)-
dependent protein deacetylases and known to counter 
aging in yeast. Now, years later, a large volume of data, 
particularly from mammals, begins to illustrate an elaborate 
set of physiological adaptations to caloric intake mediated 
by SIRT. Studies that connect SIRT activation with 
prevention of aging and diseases of aging in mouse models 
are many. It is also clear that other nutrient sensors, such 
as  adenosine monophosphate-activated protein kinase 
(AMPK) (125), mammalian TOR (mTOR) (126), and 
forkhead box O (FOXO) (127) are very important in linking 
diet, metabolism, and aging. Indeed, numerous connections 
among all of these pathways are evident in the literature.
(128) Perhaps the most direct indication that SIRT play 
an important role in the physiological adaptation to CR 
comes from a more detailed analysis of their substrates and 
physiological effects. Two hallmarks of CR are metabolic 
reprogramming to oxidative metabolism (to gain the most 
possible energy from fuel sources) and resistance to stress, 
particularly oxidative stress.(128)
 SIRT1 plays a central role in inducing mitochondrial 
biogenesis, stress tolerance, and fat metabolism. This 
SIRT deacetylates peroxisome proliferator-activated 
receptor gamma coactivator 1-alpha (PGC-1α) (129,130), 
FOXO1 (131,132), and peroxisome proliferator-activated 
receptors (PPAR)α (133). In this regard, SIRT1 activity 
is tightly linked to AMPK (134,135), since AMPK drives 
expression of the NAD+ synthetic enzyme nicotinamide 
phosphoribosyltransferase (NAMPT) (136,137), and SIRT1 
deacetylates and activates the AMPK activator kinase liver 
kinase B1 (LKB1) (138,139). At the same time, SIRT1 turns 
down glycolytic metabolism by deacetylating glycolytic 
enzymes (140) and one of their key transcriptional inducers, 
hypoxia-inducible factor (HIF)-1α (141). These SIRT 
functions may help explain the global anti-inlammatory 
effect of CR, which may be an important mechanism by 
which this diet slows aging. Indeed, NF-κB activation has 
been linked to aging (142), a topic explored further below.
 SIRT1 was irst linked to circadian control via the 
peripheral and autonomous clock in the liver. In this 
tissue, SIRT1 deacetylates circadian clock proteins Brain 
and Muscle ARNT-Like (BMAL)1 and period circadian 
clock 2 (PER2) (143,144) to inluence their function. In 
the liver, the clock also regulates NAMPT, rendering SIRT 
activity circadian and providing a link between the clock 
and metabolism (145,146). Interestingly, SIRT1 has been 
shown recently to also control central circadian function 
in the brain by amplifying expression of BMAL1.(147) 
Importantly, SIRT1 levels decline in the suprachiasmatic 
nucleus (SCN) of aged mice compared with young controls. 
This decline is concomitant with the reduction of many 
of the components of the circadian clock, presumably 
triggering the degradation of central circadian function 
with aging.(148) Remarkably, overexpressing SIRT1 in 
the brain blunts the effects of aging on circadian function, 
and deletion of SIRT1 compromises function in young 
animals. SIRT1 deacetylates PGC-1α in neurons to increase 
activation of BMAL transcription. Thus, a loop of SIRT1, 
PGC-1α, and NAMPT ampliies the expression of circadian 
clock proteins and assures proper central circadian function 
in the SCN.(147)
 Resveratrol is a polyphenol that is found in grapes 
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and in red wine. Its potential to promote lifespan was 
irst identiied in yeast (149), and it has since gained fame 
because it was suggested to be responsible for the so-called 
French paradox. In monkeys fed a diet high in sugar and 
fat, resveratrol supplementation attenuated peripheral 
inlammation in adipose tissue (150), maintained pancreatic 
homeostasis by preventing βcell dedifferentiation (151), 
and improved vascular function, particularly pulse wave 
velocity (152). Resveratrol treatment prolongs the lifespan 
of mice fed a high-fat diet or fed every other day (153), but 
not of mice on regular chow. This polyphenolic compound 
prolongs the life of lies (154), worms (155), and the 
replicative lifespan of yeast (149).
 The mechanisms behind these effects may rely on the 
fact that resveratrol mimics some of the metabolic actions 
of CR, as a series of studies on humans have suggested.
(156) Resveratrol interacts with many stress-related targets 
in the cell, including the mammalian NAD+-dependent 
deacetylase SIRT1 (155,157), although the resveratrol-
SIRT1 interaction may be indirect (158). SIRT1 is a member 
of a family of proteins (SIRT) that have been linked to 
longevity in yeast, lies, and worms.(123,159,160)
 The aging-associated reorganization of chromatin’s 
structure supports the idea that chromatin-remodeling 
factors play an important role in the aging process. Histone-
modifying enzymes are also important contributors in the 
aging process.(10,11) It is also well known that SIRT, 
NAD+-dependent histone deacetylases, are important 
players in the aging process. Therefore, due to its pleiotropic 
effects, SIRT1 could be involved in modulating aging at 
multiple levels, including: gene transcription; cell cycle; 
signal transduction; stress response; chromatin structure; 
DNA repair, and genomic integrity.
 The aging-associated changes in the nuclear 
architecture, chromatin structure, altered expression and 
activity of chromatin remodeling factors, and change in 
pattern of epigenetic marks (DNA methylation and histone 
modiication) affect all cells in the adult body including 
the population of stem cells responsible for proper tissue 
rejuvenation. Therefore, the elucidation of these precise 
mechanisms will help to develop more eficient anti-aging 
strategies as well as facilitate a better understanding of age-
related risks for cancer genesis.(12)
Aging tissues experience a progressive decline in 
homeostatic and regenerative capacities, which has been 
attributed to degenerative changes in tissue-speciic stem 
cells, stem cell niches and systemic cues that regulate stem 
cell activity. ASCs, or resident stem cells, are undifferentiated 
cells found in adults throughout life.(162) These cells 
are characterized by two developmental capacities: self-
renewal, the ability to give rise to daughter stem cells, and 
multipotency, the capacity to differentiate into various cell 
types of a particular organ. These properties provide stem 
cells the ability to sustain their population during life, and 
to maintain tissue remodeling and repair (15), facilitating 
the rationale for using ASC in regenerative medicine (163).
 Stem cell function declines with age and this occurs 
at multiple levels, including self-renewal and differentiation 
potential, leading to reduced regenerative capacity of all 
tissues and organs. Moreover, age-related alterations in stem 
cells contribute to distinct pathophysiological characteristics 
depending on the tissue of origin and function. Thus, 
given the perspectives of ASC in regenerative therapy, 
understanding these processes and their role in age-related 
diseases is vital.(19)
 An interesting addition to the data supporting a 
signiicant epigenetic contribution to stem cell aging 
comes from the apparent ability of some ASC to reacquire 
a youthful ability to regenerate their tissue compartments 
through changes in their microenvironment. Repair/
regeneration of the skeletal muscles is most probably 
performed by satellite cells, a stem cell population residing 
beneath the basal lamina of the myoibers.(164) Muscle 
damage results in an inlammatory response causing the 
normally quiescent satellite cells to proliferate and migrate 
to the site of damage. The age-related decline in muscle 
mass and strength known as sarcopenia is thought to result, 
at least in part from compromised satellite cell function. A 
more interesting demonstration of functional rejuvenation 
comes from heterochronic parabiosis experiments in which 
the circulatory system of old and young animals was 
surgically joined.(13,165) Satellite cells isolated from old 
humans and mice show similar functional defects in their 
notch and  TGFβ signaling pathways but factors present 
in the peripheral blood of young mice are able to restore 
these to a state of activity similar to those of young mouse 
satellite cells. These data imply that the age-related decline 
in satellite cell function may not arise because of irreversible 
errors such as the accumulation of DNA damage but may be 
due to reversible epigenetic changes.(18)
 An alternative explanation for the effects of 
microenvironment on stem cell function could be the SASP 
(80,166) in which the progressive accumulation of senescent 
cells within a tissue alters the microenvironment by secreting 
various factors such as IL-6. The regulation of senescent 
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cell accumulation and impact upon the progression of an 
aged phenotype are not clear but published data suggest that 
that removal of senescent cells can prevent or delay tissue 
dysfunction.(109)
 The rejuvenating effects of a young systemic 
environment do not appear to be restricted to the skeletal 
muscles. Neurogenesis is subject to an age-related decline 
in the murine central nervous system (CNS) (31,167,168) 
but this seems to be partially rescued in heterochronic 
parabionts (51). Again, the decline in neurogenesis seems 
to be reversible by other factors since deletion of the Wnt 
antagonist Dickkopf1 (DKK1) (whose expression increases 
during normal aging of the CNS) (169) can increase the self 
renewal of neural stem cells and contribute to improved 
spatial learning and memory in older mice, while increases 
in the level of the cytokine C-C motif chemokine 11 
(CCL11) in the blood of young mice are suficient to reduce 
neurogenesis and CNS function. These observations appear 
to support an epigenetic contribution to aging but at present 
there are insuficient data from which to draw clearer 
conclusions. By analogy to the attainment of a pluripotent 
state by epigenetic reprogramming of a differentiated cell, 
is cellular rejuvenation by heterochronic parabiosis, NF-
κB inhibition, or inhibition of mTOR signaling (Figure 5) 
a form of epigenetic reprogramming from an aged state to 
a youthful state? If so, then these would be examples of an 
uncoupling of the differentiation program from the aging 
clock, with cells in each case manifesting an apparent 
rewinding of the aging clock without loss of differentiation.
 Clearly, any therapeutic goal of cell or tissue 
rejuvenation would aim to restore a “young adult” state 
from an elderly state, not rewinding the aging clock back 
to embryonic or even postnatal developmental stages when 
growth and morphogenesis are paramount and the systemic 
milieu is very different from that in the adult. The challenge 
would be to reset the aging clock back to the appropriate 
adult stage. Another challenge is the coordination of 
reprogramming among different cell types in multicellular 
organisms. As such, the most feasible near-term applications 
of any type of rejuvenating intervention for therapeutic 
purposes would be those that could be administered in 
a temporally and spatially controlled manner (e.g., to a 
speciic site of wound repair or tissue injury for a limited 
time).(3)
 Aging is characterized by a progressive decline in 
metabolic homeostasis. A comprehensive insight into 
cellular processes that respond to metabolic imbalances 
will be useful in identifying new avenues for therapeutic 
intervention against age-related diseases. Mitochondria 
play a central role in such processes, as they are the hubs 
of metabolic activity in eukaryotic cells and signiicantly 
inluence the intracellular energy balance and redox milieu. 
Figure 5. Rejuvenation without Dedifferentiation.(6) (Adapted 
with permission from Elsevier Inc)
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The function of mitochondria as sensors of metabolic 
imbalances and as mediators of speciic cellular stress 
responses that can impact longevity has recently garnered 
increased attention. Mitochondrial dysfunction has long 
been implicated in aging, primarily as a source of metabolic 
stress and of reactive oxygen species.(170,171)
 CR enhanced endogenous muscle repair and CR 
initiated in either donor or recipient animals improved the 
contribution of donor cells to regenerating muscle after 
transplant. These studies indicate that metabolic factors 
play a critical role in regulating stem cell function and 
that this regulation can inluence the eficacy of recovery 
from injury and the engraftment of transplanted cells.(49) 
SIRT3 is dispensable for HSC maintenance and tissue 
homeostasis at a young age under homeostatic conditions 
but is essential under stress or at an old age. Importantly, 
SIRT3 is suppressed with aging, and SIRT3 upregulation in 
aged HSCs improves their regenerative capacity. This study 
illuminates the plasticity of mitochondrial homeostasis 
controlling stem cell and tissue maintenance during the 
aging process and shows that aging-associated degeneration 
can be reversed by a SIRT.(8)
 Now it is well accepted that SIRT play important 
roles in a broad spectrum of biological processes, although 
questions still remain. SIRT function to slow aging and 
various disorders associated with aging, including metabolic 
diseases, cancer, and neurodegenerative conditions. SIRT 
Figure 6. Common pathways contributing to stem cell loss and dysfunction in the aging process. Common aging phenotypes within 
the stem cell are shown in red, in the niche in pink, and the strategies by which to target and hopefully reverse these mechanisms in purple.
(161) (Adapted with permission from Nature Publishing Group)
respond to the energy availability provided by the diet to 
determine the acetylation status of histones, key transcription 
factors, and metabolic enzymes. This coordinated response 
helps deliver the beneits of CR on health and physiology. 
Indeed, Resveratrol have been shown to target SIRT1 
directly (172,173), and present a promising strategy to 
ameliorate age-related diseases. Novel drugs for other SIRTs 
may also become available and offer additional beneits. 
And inally, NAD+ supplementation in combination with 
SIRT-activating compound (STAC) may offer a synergetic 
strategy to promote healthy aging.(6)
 Understanding the molecular processes controlling 
stem cell survival, self-renewal, quiescence, proliferative 
expansion and commitment to speciic differentiated cell 
lineages is crucial to determining the drivers and effectors 
of age-associated stem cell dysfunction. Furthermore, 
such knowledge will be essential to inform development 
of therapeutic interventions that can slow, and perhaps 
reverse, age-related degenerative changes to enhance repair 
processes and maintain healthy function in aging tissues. In 
the context of conserved cellular processes, accumulation of 
toxic metabolites, DNA damage, proteostasis, mitochondrial 
dysfunction, proliferative exhaustion, extracellular signaling 
and epigenetic remodeling that clearly affect the activity of 
both stem cells and non-stem cells with age and may be 
linked to mechanisms that determine organismal lifespan 
and healthspan (Figure 6).(161)
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